Quetiapine
- Product NDC
- 71093-139
- 11-digit product format
- 710930139
- Labeler code
- 71093
- Product ID
- 71093-139_8a3515c7-6fc7-4150-a898-23443e4802fd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Quetiapine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- ACI Healthcare USA, Inc.
- Application
- ANDA209635
- Marketing category
- ANDA
- Marketing start
- 2017-11-29
- Substance
- QUETIAPINE FUMARATE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209635-001 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | |
| A209635-002 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | |
| A209635-003 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | |
| A209635-004 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | |
| A209635-005 | QUETIAPINE FUMARATE | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2018-11-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209635-001 | AB |
| A209635-002 | AB |
| A209635-003 | AB |
| A209635-004 | AB |
| A209635-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209635-001 | QUETIAPINE FUMARATE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209635-002 | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209635-003 | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209635-004 | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-11-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209635-005 | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2018-11-16 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209635-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209635-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209635-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209635-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209635-005 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quetiapine Extended Release | QUETIAPINE | REMEDYREPACK INC. | 995731f7-aace-4140-b699-d6e8975c7c83 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Extended Release | QUETIAPINE | NuCare Pharmaceuticals, Inc. | 44e9b338-b163-bee7-e063-6394a90a1338 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Extended Release | QUETIAPINE | Golden State Medical Supply, Inc. | 04cd529c-198b-5b85-e063-6294a90a4684 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Extended Release | QUETIAPINE | ST. MARY'S MEDICAL PARK PHARMACY | 3622cbd4-d7cb-57d4-e063-6294a90a5f24 | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Extended Release | QUETIAPINE | ScieGen Pharmaceuticals, Inc | 5e4a84b1-fb8c-44d0-8213-51e43d71db69 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Fumarate ER | QUETIAPINE FUMARATE ER | Direct_Rx | 0917ef53-2647-b54b-e063-6294a90a4211 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Fumarate ER | QUETIAPINE FUMARATE ER | Direct_rx | 23820efc-4df7-9dc9-e063-6394a90a0bb4 | 2024-10-02 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 |
| Quetiapine Extended Release | QUETIAPINE | ACI Healthcare USA, Inc. | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 2021-01-28 | Boxed warning, Warnings, Adverse reactions | 209635 ANDA209635 71093-139 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Quetiapine
- Brand name suffix
- Extended Release
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| QUETIAPINE FUMARATE | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2S3PL1B6UJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5ef42f82-f087-0d2c-105f-f791ca69210e | Product name | 8 | 20250729 |
| 21205abd-8c89-4943-9f85-908f3d4fc3bb | Product name | 5 | 20230501 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71093-139-02 | QuetiapineExtended Release | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71093-139-02 | EA - Each | 71093-139 | 3008fc59-ba17-4b4e-9543-fba4b5f83bcf | 1 | 2018-02-20 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 895670 | QUEtiapine fumarate 150 MG 24HR Extended Release Oral Tablet | PSN | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721791 | QUEtiapine fumarate 200 MG 24HR Extended Release Oral Tablet | PSN | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721794 | QUEtiapine fumarate 300 MG 24HR Extended Release Oral Tablet | PSN | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721796 | QUEtiapine fumarate 400 MG 24HR Extended Release Oral Tablet | PSN | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 853201 | QUEtiapine fumarate 50 MG 24HR Extended Release Oral Tablet | PSN | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 895670 | 24 HR quetiapine 150 MG Extended Release Oral Tablet | SCD | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721791 | 24 HR quetiapine 200 MG Extended Release Oral Tablet | SCD | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721794 | 24 HR quetiapine 300 MG Extended Release Oral Tablet | SCD | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721796 | 24 HR quetiapine 400 MG Extended Release Oral Tablet | SCD | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 853201 | 24 HR quetiapine 50 MG Extended Release Oral Tablet | SCD | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 895670 | quetiapine 150 MG (as quetiapine fumarate 173 MG) 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 895670 | quetiapine 150 MG 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721791 | quetiapine 200 MG (as quetiapine fumarate 230 MG) 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721791 | quetiapine 200 MG 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721794 | quetiapine 300 MG (as quetiapine fumarate 345 MG) 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721794 | quetiapine 300 MG 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 721796 | quetiapine 400 MG (as quetiapine fumarate 461 MG) 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 853201 | quetiapine 50 MG (as quetiapine fumarate 58 MG) 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
| 853201 | quetiapine 50 MG 24 HR Extended Release Oral Tablet | SY | 07e4f3f4-42cb-4b22-bf8d-8c3279d26e97 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71093-139-02 | 71093013902 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71093-139-02) | 2018-02-01 | 0000-00-00 | No | No | Current |